The U.S. Navy is stepping up efforts to clamp down on steroid use by agency personnel, recent contracting documents show. The Naval Logistics Medical Command, through its Ft. Detrick, Md.-based Bureau of Medicine and Surgery, is assessing the availability of qualified labs capable of conducting about 400 steroid-specific urine-specimen analyses annually over the next five years. According to a sources-sought notice dated Dec. 12 and located via a routine search of the FedBizOpps database, the endeavor aims to detect the use of performance-enhancing drugs listed in the Anabolic Steroid Act of 2004, such as 19-nor-androsterone, Boldenone, Nandrolone, Stanozolol, Methandienone, Drostanonlone, Trenbolone, Methenolone, as well as other compounds. Though unconnected to the recent spate of high-profile cases in the media, the stepped-up testing coincides with the release of a Major League Baseball report revealing pervasive steroid use among professional ball players (see Steroid Report Names Star Players; Washington Post, 12/14/2007; free registration required).